Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806100 · ClinicalTrials.gov registry record · NA

Effects of Malleo-Lok Stiffness on Lower Limb Mechanics

A NA study of Healthy and Adult ALL, sponsored by University of Iowa.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04806100: Completed NA study of Healthy and Adult ALL, sponsored by University of Iowa.

NCT04806100 is a NA study of Healthy and Adult ALL that has completed, run by University of Iowa. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806100, a NA study of Healthy and Adult ALL, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this research study is to determine if the stiffness of a commercially available ankle foot orthosis (Malleo-Lok, Bio-Mechanical Composites, Des Moines IA) impacts gait biomechanics and overall joint level stiffness. Previously published research suggests that AFO stiffness can affect gait biomechanics and patient preference. However, previous studies have focused on traditional posterior strut devices with the strut aligned in the frontal plane to allow sagittal plane deflection. The Malleo-Lok is a novel, low-profile carbon fiber device with two laterally positioned struts aligned in the sagittal plane. The proposed study will provide insight that can be used by certified prosthetists orthotists (CPOs), physical therapists, and physicians to select the device that bests meets their patients' needs.

Primary Outcome

Ground reaction force and ankle motion data were collected simultaneously using the force measurement and motion capture systems as participants wore no brace (NoCDO), a moderate stiffness orthosis (Compliant) and a stiff orthosis (Stiff) in a randomized order. The ankle motion data was plotted against the ankle moment data and the slope of the corresponding line was the resulting ankle joint stiffness (Nm/degree).

Conditions Studied

Interventions

  • DEVICE Malleo-Lok

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-03-11
Est. Completion 2021-10-20
Phase NA
University of Iowa

228 total trials

What the finished NCT04806100 record still lists

NCT04806100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Malleo-Lok is the first listed.

NCT04806100 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT04806100 about?

NCT04806100 is a clinical study titled "Effects of Malleo-Lok Stiffness on Lower Limb Mechanics". The primary purpose of this research study is to determine if the stiffness of a commercially available ankle foot orthosis (Malleo-Lok, Bio-Mechanical Composites, Des Moines IA) impacts gait biomechanics and overall joint level stiffness. Previously published research suggests that AFO stiffness ca...

What is the current status of trial NCT04806100?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-03-11. Estimated completion is 2021-10-20.

What conditions does trial NCT04806100 study?

This clinical trial studies the following conditions: Healthy, Adult ALL.

What interventions are being tested in trial NCT04806100?

The interventions under investigation include: Malleo-Lok (DEVICE).

Who is sponsoring clinical trial NCT04806100?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04806100 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04806100's enrollment target sits among peer trials

20 861st of 1090 higher than 194 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

  • NCT01630850 · 20 participants · NA

    Islet Transplantation in Patients With "Brittle" Type I Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04806100, the US trial registry maintained by the National Library of Medicine. NCT04806100 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.